<<I'd be surprised (based on the animal data) if analgesia were lost.>>
The slide Stoll presented, showing rescue in the rat model at 900mg, 1500mg and 2100mg, clearly showed a response that seemed to corolate to dose level.
I listened to Stoll this morning and he could have done a lot to clear up confusion over the procedural issues...but didn't. My take is the same as yours; the science is probably clean, but I still maintain that major potential investors will wait for validation.
Personally, I'm happy with today's action and close. We closed strongly above the 200 EMA on heavy volume. The channel is intact and we should move higher over the next few weeks. Any move into the bottom half of the channel is a buying opportunity. My only concern is the A/D line. We have had some massive distribution (i.e., selling) into the rally during the last few days.
News 
Market Data 
Discover 
AI
